Requirement for DARPP-32 in mediating effect of dopamine D2 receptor activation

European Journal of Neuroscience

Volumn 11, Issue 7, 1999, Pages 2589-2592

  Nishi, A ^a   Snyder, G L ^a   Fienberg, A A ^a   Fisone, G ^a   Aperia, A ^a   Nairn, A C ^a   Greengard, P ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

D1 receptor; K+ ATPase; Mouse; Na+; Neostriatum; Protein phosphatase 1

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; PHOSPHOPROTEIN DARPP 32;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPHOSPHORYLATION; DOPAMINERGIC ACTIVITY; HUMAN; ION TRANSPORT; MALE; MOUSE; NEOSTRIATUM; PRIORITY JOURNAL;

ANIMALS; DOPAMINE AGONISTS; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FENOLDOPAM; MALE; MICE; MICE, INBRED C57BL; MUTATION; NA(+)-K(+)-EXCHANGING ATPASE; NEOSTRIATUM; NERVE TISSUE PROTEINS; NEURONS; PHOSPHOPROTEINS; QUINPIROLE; RECEPTORS, DOPAMINE D2;

EID: 0033043842     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1999.00724.x     Document Type: Article

References (18)